NCT06132919View on ClinicalTrials.gov

Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS)

PHASE2CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

October 11, 2023

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2024

Conditions

Vulvar Lichen Sclerosus

Interventions

DRUG

MC2-25 cream

Topical application

DRUG

MC2-25 vehicle

Topical application

Trial Locations (1)

Unknown

MC2 Therapeutics study site, Kolding

Sponsors

Lead Sponsor

MC2 Therapeutics

All Listed Sponsors

lead

MC2 Therapeutics

INDUSTRY